- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07780734
FACTORS AFFECTİNG ENTERAL FEEDİNG INTOLERANCE İN INTENSİVE CARE UNİT PATİENTS (EFI-ICU)
FACTORS AFFECTİNG ENTERAL FEEDİNG INTOLERANCE İN INTENSİVE CARE UNİT PATİENTS: A PROSPECTİVE OBSERVATİONAL STUDY
Enteral nutrition is the first-line nutritional support method in critically ill patients because it helps preserve gastrointestinal system integrity, reduce the risk of infection, and meet metabolic requirements. However, gastrointestinal motility is frequently impaired in critically ill patients due to physiological stress, hemodynamic instability, sedative and vasopressor medications, mechanical ventilation, and underlying diseases. This may result in enteral feeding intolerance (EFI), which complicates nutritional management.
This prospective observational study aims to determine the demographic, clinical, laboratory, and treatment-related factors associated with enteral feeding intolerance in adult intensive care unit patients and to evaluate the association between enteral feeding intolerance and morbidity and mortality.
Adult patients who are started on enteral nutrition in the Anesthesiology and Reanimation Intensive Care Unit will be prospectively followed. No additional intervention will be performed. Patients will be monitored according to routine intensive care and enteral nutrition protocols. Enteral feeding intolerance and potentially associated factors will be recorded prospectively.
The study is planned to include 102 patients.
연구 개요
상태
상세 설명
Enteral nutrition is an important component of nutritional support in critically ill patients. However, enteral feeding intolerance is frequently observed in intensive care units and may result from impaired gastrointestinal motility associated with critical illness, hemodynamic instability, sedative and vasopressor use, mechanical ventilation, and underlying diseases.
In this study, demographic, clinical, laboratory, physiological, nutritional, and treatment-related variables that may affect the development of enteral feeding intolerance will be evaluated prospectively.
All adult patients admitted to the intensive care unit who are planned to receive enteral nutrition will be screened daily. Patients meeting the eligibility criteria will be enrolled after informed consent has been obtained from the patient or legally authorized representative.
Because this is an observational study, there will be no randomization and no investigator-assigned intervention. Patients will be classified according to their natural clinical course into an enteral feeding intolerance group and a non-enteral feeding intolerance group.
Demographic characteristics, admission diagnosis, APACHE II, SOFA, and Glasgow Coma Scale scores will be recorded. Daily clinical variables including bowel sounds, presence of stool, sedation, opioid use, vasopressor requirement, sepsis, and aspiration pneumonia will also be recorded.
Routine laboratory parameters including total protein, albumin, C-reactive protein, procalcitonin, lactate, hemoglobin, leukocyte count, and lymphocyte count will be obtained from the hospital electronic medical record twice weekly according to routine clinical practice.
The modified Nutrition Risk in Critically Ill (mNUTRIC) score and Prognostic Nutritional Index (PNI) will be calculated. Mechanical ventilation characteristics, enteral nutrition initiation time, formula type, daily energy and protein targets, delivered amounts, and interruptions of enteral nutrition will be recorded.
Enteral feeding intolerance will be assessed according to predefined criteria and international recommendations. The following findings will be considered enteral feeding intolerance: vomiting, a single gastric residual volume greater than 250 mL, a 24-hour gastric residual volume greater than 500 mL, abdominal distension, and suspected aspiration.
Gastric residual volume will be measured by intensive care nurses using a 50-mL syringe according to the standard intensive care unit protocol.
Intra-abdominal pressure will be measured twice weekly as part of routine intensive care practice using the Foley bladder pressure measurement technique.
All study data will be obtained from routine clinical records, laboratory results, enteral nutrition monitoring charts, ventilator records, and the hospital electronic medical record. No additional invasive procedure, imaging study, surgical procedure, or other intervention will be performed for research purposes.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Eda Cirit Bardakci, Medical Doctor
- 전화번호: +90 541 308 9295
- 이메일: edacrt@gmail.com
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
The study population will consist of adult patients aged 18 years or older who are admitted to the Anesthesiology and Reanimation Intensive Care Unit of Ankara Atatürk Sanatoryum Training and Research Hospital and who are started on enteral nutrition.
Patients will be prospectively screened and consecutively enrolled if they meet all inclusion criteria and none of the exclusion criteria.
설명
Inclusion Criteria:
- Age ≥18 years
- Admission to the Anesthesia Intensive Care Unit
- Enteral nutrition planned or initiated during intensive care unit admission
- Expected to require enteral nutrition during intensive care unit follow-up
- Availability of sufficient clinical and nutritional data for study evaluation
- Patient or legally authorized representative provides informed consent when required by the ethics protocol
Exclusion Criteria:
- Age <18 years
- Patients receiving only parenteral nutrition
- Patients in whom enteral nutrition is contraindicated throughout the observation period
- Patients with insufficient data for evaluation of enteral feeding tolerance
- Patients transferred to another intensive care unit before adequate study assessment
- Patients who decline participation or whose legally authorized representative declines participation when consent is required
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Occurrence of Enteral Feeding Intolerance
기간: 7 days
|
Enteral feeding intolerance will be defined by the presence of at least one predefined clinical criterion: vomiting, a single gastric residual volume greater than 250 mL, 24-hour cumulative gastric residual volume greater than 500 mL, abdominal distension, or clinical suspicion of aspiration related to enteral feeding.
|
7 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Achievement of Energy Target
기간: 3 days
|
The proportion of prescribed or calculated daily energy target actually delivered through enteral nutrition.
Achievement of ≥70-80% of the calculated daily energy target will be considered adequate.
|
3 days
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- 2024-BCEK/483
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .